NOVI, Mich., April 15, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the first quarter 2025 on Thursday, April 24, 2025, and will host a conference call to discuss those results at 8 am (ET) that same day.

Conference Call
Toll-free dial-in number: 1-877-407-4018
International dial-in number: 1-201-689-8471
Conference ID number: 13753379

Webcast
A live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm's website at www.gentherm.com.

A telephonic replay will be available approximately two hours after the call by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13753379. The replay will be available until 11:59 p.m. (ET) on May 8, 2025.

Investor Contact 
Gregory Blanchette
investors@gentherm.com  
248.308.1702

Media Contact 
Melissa Fischer 
media@gentherm.com   
248.289.9702 

About Gentherm 
Gentherm (NASDAQ: THRM) is a global market leader of innovative thermal management and pneumatic comfort technologies. Automotive products include variable temperature Climate Control Seats^®, heated automotive interior systems (including heated seats, steering wheels, armrests, and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Mexico, Morocco, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.